BCG Matrix and VRIO Framework for Birzeit Pharmaceutical Company Marketing from Palestine

Posted by Sophia Morgan on Jul-30-2018

BCG Matrix

The BCG matrix is a strategic management tool that was created by the Boston Consulting Group, which helps in analysing the position of a strategic business unit and the potential it has to offer. The matrix consists of 4 classifications that are based on two dimensions. These first of these dimensions is the industry or market growth. The other of these dimensions is the relative market share of the strategic business unit. Strategic business units are placed in one of these 4 classifications. The BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine will help decide on the strategies that can be implemented for its strategic business units.

Strategic business units with high market growth rate and high relative market share are called stars. Businesses should invest in their stars and can implement vertical integration, market penetration, product development, market development, and horizontal integration strategies. Strategic business units with high market growth rate and low relative market share are called question marks. These strategic business units require close considerations whether the business should continue with them or divest. Strategic business units with low market growth rate but with high relative market share are called cash cows. The business should invest in these to maintain their relative market share. Lastly, the strategic business units with low market growth rate and low relative market share are called dogs. The business should divest these strategic business units.

BCG Matrix of Birzeit Pharmaceutical Company Marketing from Palestine

The BCG Matrix for Birzeit Pharmaceutical Company Marketing from Palestine will help Birzeit Pharmaceutical Company Marketing from Palestine in implementing the business level strategies for its business units. The analysis will first identify where the strategic business units of Birzeit Pharmaceutical Company Marketing from Palestine fall within the BCG Matrix for Birzeit Pharmaceutical Company Marketing from Palestine.

Stars

  • The financial services strategic business unit is a star in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine. It operates in a market that shows potential in the future. Birzeit Pharmaceutical Company Marketing from Palestine earns a significant amount of its income from this SBU. Birzeit Pharmaceutical Company Marketing from Palestine should vertically integrate by acquiring other firms in the supply chain. This will help it in earning more profits as this Strategic business unit has potential.
  • The Number 1 brand Strategic business unit is a star in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine, and this is also the product that generates the greatest sales amongst its product portfolio. The potential within this market is also high as consumers are demanding this and similar types of products. Birzeit Pharmaceutical Company Marketing from Palestine should undergo a product development strategy for this SBU, where it develops innovative features on this product through research and development. This will help Birzeit Pharmaceutical Company Marketing from Palestine by attracting more customers and increases its sales.
  • The Number 2 brand Strategic business unit is a star in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine as Birzeit Pharmaceutical Company Marketing from Palestine has a 20% market share in this category. It also the market leader in this category. The overall category is expected to grow at 5% in the next 5 years, which shows that the market growth rate is expected to remain high. Birzeit Pharmaceutical Company Marketing from Palestine should use its current products to penetrate the market. This could be done by improving its distributions that will help in reaching out to untapped areas. This will help increase the sales of Birzeit Pharmaceutical Company Marketing from Palestine.

Cash Cows

  • The supplier management service strategic business unit is a cash cow in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine. This has been in operation for over decades and has earned Birzeit Pharmaceutical Company Marketing from Palestine a significant amount in revenue. The market share for Birzeit Pharmaceutical Company Marketing from Palestine is high, but the overall market is declining as companies manage their supplier themselves rather than outsourcing it. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to stop further investment in this business and keep operating this strategic business unit as long as its profitable.
  • The Number 3 brand strategic business unit is a cash cow in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine. This is an innovative product that has a market share of 25% in its category. Birzeit Pharmaceutical Company Marketing from Palestine is also the market leader in this category. The overall category has been declining slowly in the past few years. Birzeit Pharmaceutical Company Marketing from Palestine has the power to influence the market as well in this category. It should, therefore, invest in research and development so that the brand could be innovated. This will help the category grow and will turn this cash cow into a star. The overall benefit would be an increase in sales of Birzeit Pharmaceutical Company Marketing from Palestine.
  • The international food strategic business unit is a cash cow in the BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine. This business unit has a high market share of 30% within its category, but people are now inclined less towards international food. This change in trends has led to a decline in the growth rate of the market. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to invest enough to keep this strategic business unit under operations. If it no longer remains profitable and turns into a dog, then Birzeit Pharmaceutical Company Marketing from Palestine should divest this strategic business unit.

Question Marks

  • The local foods strategic business unit is a question mark in the BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine. The recent trends within the market show that consumers are focusing more towards local foods. Therefore, this market is showing a high market growth rate. However, Birzeit Pharmaceutical Company Marketing from Palestine has a low market share in this segment. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to invest in research and development to come up with innovative features. This product development strategy will ensure that this strategic business unit turns into a cash cow and brings profits for the company in the future.
  • The Number 4 brand strategic business unit is a question mark in the BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine. This strategic business unit is a part of a market that is rapidly growing. However, this strategic business unit has been incurring losses in the past few years. It has also failed in the attempts made at innovation by research and development teams. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to divest and prevent any future losses from occurring.
  • The confectionery strategic business unit is a question mark in the BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine. The confectionery market is an attractive market that is growing over the years. However, Birzeit Pharmaceutical Company Marketing from Palestine has a low market share in this attractive market. The low sales are as a result of low reach and poor distribution of Birzeit Pharmaceutical Company Marketing from Palestine in this segment. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to undergo market penetration, where it pushes to make its product present on more outlets. This will ensure increased sales for Birzeit Pharmaceutical Company Marketing from Palestine and convert this strategic business unit into a cash cow.

Dogs

  • The plastic bags strategic business unit is a dog in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine. This strategic business unit has been in the loss for the last 5 years. It also operates in a market that is declining due to greater environmental concerns. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to divest this strategic business unit and minimise its losses.
  • The Number 5 brand strategic business unit is a dog in the BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine. This is operating in a market segment that is declining in the past 5 years. The company also has negative profits for this strategic business unit. However, it is expected that the market will grow in the future with environmental changes that are occurring. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to invest in the business enough to convert into a cash cow. This will ensure profits for Birzeit Pharmaceutical Company Marketing from Palestine if the market starts growing again in the future.
  • The synthetic fibre products strategic business unit is a dog in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine. The market for such products has been declining, and as a result of this decline, Birzeit Pharmaceutical Company Marketing from Palestine has been facing a loss in the past 3 years. The market share for it is also less than 5%. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to divest this strategic business unit to minimise any further losses.
  • The artificially flavoured products strategic business unit is a dog in the BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine. These products were launched recently, with the prediction that this segment would grow. However, with increasing health consciousness, people are now refraining from consumption of artificial flavours. The market is shrinking, and Birzeit Pharmaceutical Company Marketing from Palestine has no significant market share. The recommended strategy for Birzeit Pharmaceutical Company Marketing from Palestine is to call back this product.

Some of the strategic business units identified in the BCG matrix for Birzeit Pharmaceutical Company Marketing from Palestine have the potential of changing from their current classification. For example, a dog changing to a cash cow. These have been identified in the BCG matrix of Birzeit Pharmaceutical Company Marketing from Palestine and recommended strategies to ensure such change have also been made.

VRIO Framework

The VRIO Framework or VRIO analysis is a strategic management tool that is used to analyse a firm’s internal strengths and resources. It helps identify which one of its internal strengths and resources can be a source of sustained competitive advantage. The analysis is based on the idea that a firm’s internal resources are a source of sustained competitive advantage if they are valuable, rare, cannot be imitated by competition, and are organised to capture value for the organisation. The VRIO analysis requires looking at a firm's resources based on these 4 factors.

Based on the analysis, each resource can either provide a sustained competitive advantage, has a good competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage. A sustained competitive advantage exists when a resource is valuable, rare, non-imitable and organised. A good competitive advantage occurs if it is valuable, rare, and non-imitable. A temporary competitive advantage exists if it is valuable and rare. A competitive parity occurs if it is only valuable. Lastly, the resource is a competitive disadvantage if it is neither of the 4. The analysis takes place in this order by first assessing whether a resource is valuable, rare, imitable and organised.

References

Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of management, 17(1), 99-120.

Barney, J. (2002). Gaining and Sustaining Competitive Advantage, 2nd ed. Prentice Hall, Upper Saddle River, NJ.

Cardeal, N., & Antonio, N. S. (2012). Valuable, rare, inimitable resources and organization (VRIO) resources or valuable, rare, inimitable resources (VRI) capabilities: What leads to competitive advantage?

Hambrick, D. C., MacMillan, I. C., & Day, D. L. (1982). Strategic attributes and performance in the BCG matrix—A PIMS-based analysis of industrial product businesses. Academy of Management Journal, 25(3), 510-531.

Jurevicius, O. (2013a). VRIO Framework. Retrieved from https://www.strategicmanagementinsight.com/tools/vrio.html

Jurevicius, O. (2013b). BCG growth-share matrix. Retrieved from https://www.strategicmanagementinsight.com/tools/bcg-matrix-growth-share.html

Knott, P. J. (2015). Does VRIO help managers evaluate a firm’s resources? Management Decision, 53(8), 1806-1822.

Seeger, J. A. (1984). Research note and communication. Reversing the images of BCG's growth/share matrix. Strategic Management Journal, 5(1), 93-97.

Smith, M. (2002). Derrick's Ice–Cream Company: applying the BCG matrix in customer profitability analysis. Accounting education, 11(4), 365-375.

9416 Students
can’t be wrong

2084499

Orders

4.9/5

Reviews

1144

PhD Experts

Be a great writer or hire a greater one!

Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.

hire us now
Our Guarantees
Interesting Fact
Interesting Fact

Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!

Allow Our Skilled Essay Writers to Proficiently Finish Your Paper.

Hi there !

We are here to help. Chat with us on WhatsApp for any queries.

Maryam
Customer Representative